Last month, Baxter International Inc. and Baxter Healthcare Corporation settled a qui tam False Claims Act case with the Department of Justice for $18 million. The settlement is not monumental in terms of the amount, but does highlight the unique theory of FCA liability.
The White House issued an executive order on January 30, 2017 requiring agencies and executive departments to "identify at least two existing regulations to be repealed" whenever they propose or promulgate a new regulation.
Please join us for a free webinar (noon-1:00 pm PT/3:00-4:00 pm ET) designed to help health care facilities prepare for the new CALOSHA regulation that addresses the threat of workplace violence.
At a Silicon Valley IP symposium held at the Santa Clara University School of Law on Friday, February 3, presentations by in-house counsel and prosecutors highlighted the critical importance of trade secrets to technology companies.
An Austrian hotel was a recent victim of a “ransomware” computer attack that disabled its electronic room key system and locked up its own computers. This demonstrates that hotel owners and managers should be sure IT agreements adequately address the risks of cyberattacks.
Food labeling litigation increased significantly last year, with many consumer groups alleging that products were misleadingly labeled and violated U.S. Food and Drug Administration labeling requirements.
On January 31, 2017, the General Counsel of the National Labor Relations Board released an official memorandum declaring that scholarship football players at some of the most elite college programs are employees under the National Labor Relations Act.
An Executive Order from President Trump’s first days in office raised questions about its impact on the hard-won Privacy Shield, which allows about 1,700 companies to legally transfer data between the EEA and Switzerland and the US.
On January 20, 2017, President Trump’s Chief of Staff, Reince Priebus, issued a memorandum implementing an immediate regulatory freeze of any new or pending regulations until they have been reviewed and approved by Trump Administration appointees.
Earlier this month, FDA finalized Guidance for Industry, Assessment of Abuse Potential of Drugs. This guidance is intended to assist researchers and sponsors of new drugs that may have central nervous system (CNS) activity evaluate whether the drug has abuse potential.
In this episode of Fashion Counsel, Partners Anthony Lupo and Michelle Marsh discuss copyright laws and their applications (and road blocks) to the retail sector.
In one of the Trump administration’s first official acts, White House Chief of Staff Reince Priebus issued a memorandum on January 20, 2017 implementing an immediate freeze on all pending regulations until they have been reviewed and further action has been approved.
For the second consecutive year, International Trade partner David Hamill and Canada-US.Cross Border Business Affairs director Birgit Matthiesen contributed their insights to Lead, Reach and Connect, the must-read magazine for the Automotive Parts Manufactures Association.
What is most notable about this guidance is that FDA has taken the position that this type of information may be shared before a product has been approved.
Today, January 19, 2017, FDA and USDA published a flurry of new policy documents related to the agencies’ regulation of plants, animals, and microorganisms produced using new breeding methods, like gene editing.
As the inauguration of President-elect Donald Trump nears, retailers should be paying close attention to expected seismic changes in domestic trade policy that will have an important impact on the fashion industry.
Today the Department of the Treasury’s Office of Foreign Asset Controls issued a general license that effectively removes US sanctions against Sudan (North) effective January 17, 2017.